Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

With Its Second Deal in Two Weeks, This Tiny Biotech Is Revving Up for a Run

Two weeks.

Two big deals.

Two big trading days for a promising biotech.

Shares of our "Liquid Biopsy" play TrovaGene Inc. (Nasdaq: TROV) rocketed as much as 23% today after the tiny biotech announced its second major deal in the last two weeks.

Another deal - announced back on Jan. 21 - ignited a single-day gain of 70%.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK